Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DRICH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RPL14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRP72 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PYGO2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPIE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRSS55 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ECHDC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DARS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR9-3HG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
HN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMPRSS11B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLK12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CIZ1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRMT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DDI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RHOC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKRD22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMC1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MGAT4B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on